TRANSPOSON-VERMITTELTE MULTIPLEXSEQUENZIERUNG

Patent europeic · EP1327000 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1327000
Numer da la dumonda
EP01952433
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
05-07-2001
Publitgà
16-07-2003
Concedì
09-05-2007
Stritgà
31-07-2015
Motiv
Taxa annuala betg pajada
Classas IPC
C12Q 1/68 (2006.01)
Prioritad
US 216381 P 07.07.2000
Dumonda PCT
PCT/US2001/021269 05.07.2001
Publicaziun PCT
WO2002/004674 17.01.2002
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-02-2016

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.02.2016

  2. 04-04-2013

    Adressa midada

    Owner
    Aventis Pharmaceuticals Inc., 300 Somerset Corporate Boulevard, Bridgewater, New Jersey 08807, USA → Aventis Pharmaceuticals Inc., 55 Corporate Drive, Bridgewater New Jersey 08807, USA

    Published in Swissreg on 04.04.2013

  3. 31-05-2007

    Concedì

    Published in +pat+ No 10 in 2007

Partidas

Inventur

AUGUST, Paul, R.

Danville, NH 03819, US

KEAGLE, Pamela, J.

Leominster, MA 02138, US

LONG, Henry

Cambridge, MA 02138, US

WIENCIS, Anna

Natick, MA 01760, US

CALL, Katherine

Malden, MA 02148, US

DRAPER, Michael

Plaitsow, MA 03865, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.